BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11177613)

  • 1. Improvement of clonality detection rate in multiple myeloma using fluorescent IgH PCR with different sets of primers.
    Welterlin V; Debecker A; Tschieb D; Zanetti C; Lange W; Hénon PR
    J Hematother Stem Cell Res; 2000 Dec; 9(6):983-91. PubMed ID: 11177613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
    Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
    Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies.
    Aubin J; Davi F; Nguyen-Salomon F; Leboeuf D; Debert C; Taher M; Valensi F; Canioni D; Brousse N; Varet B
    Leukemia; 1995 Mar; 9(3):471-9. PubMed ID: 7533868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions.
    Linke B; Bolz I; Pott C; Hiddemann W; Kneba M
    Leukemia; 1995 Dec; 9(12):2133-7. PubMed ID: 8609729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of immunoglobulin heavy chain genes rearrangements in B-cell leukemias, lymphomas, multiple myelomas, monoclonal and polyclonal gammopathies.
    Gleissner B; Maurer J; Thiel E
    Leuk Lymphoma; 2000 Sep; 39(1-2):151-5. PubMed ID: 10975394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of IgH PCR strategies in multiple myeloma.
    Owen RG; Johnson RJ; Rawstron AC; Evans PA; Jack A; Smith GM; Child JA; Morgan GJ
    J Clin Pathol; 1996 Aug; 49(8):672-5. PubMed ID: 8881921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method for detection of B-lymphoid clonality by polymerase chain reaction.
    Deane M; McCarthy KP; Wiedemann LM; Norton JD
    Leukemia; 1991 Aug; 5(8):726-30. PubMed ID: 1909411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.
    González D; González M; Alonso ME; López-Pérez R; Balanzategui A; Chillón MC; Silva M; García-Sanz R; San Miguel JF
    Leukemia; 2003 Jun; 17(6):1051-7. PubMed ID: 12764368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.
    Martinez-Lopez J; Martinez-Sanchez P; Garcia-Sanz R; Sarasquete ME; Ayala R; Gonzalez M; Bautista JM; Gonzalez D; San Miguel J; Garcia-Effron G; Lahuerta JJ
    J Mol Diagn; 2006 Jul; 8(3):364-70. PubMed ID: 16825510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    van Dongen JJ; Langerak AW; Brüggemann M; Evans PA; Hummel M; Lavender FL; Delabesse E; Davi F; Schuuring E; García-Sanz R; van Krieken JH; Droese J; González D; Bastard C; White HE; Spaargaren M; González M; Parreira A; Smith JL; Morgan GJ; Kneba M; Macintyre EA
    Leukemia; 2003 Dec; 17(12):2257-317. PubMed ID: 14671650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometric detection of DNA amplified with fluorescent primers: applications to analysis of clonal bcl-2 and IgH gene rearrangements in malignant lymphomas.
    Barker RL; Worth CA; Peiper SC
    Blood; 1994 Feb; 83(4):1079-85. PubMed ID: 8111048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular diagnosis of non-Hodgkin B lymphomas by capillary electrophoresis and Genescan analysis: a molecular pathology laboratory experience].
    Donisi PM; Di Lorenzo N; Paparella A; Riccardi M; Stracca-Pansa V
    Pathologica; 2006 Apr; 98(2):139-46. PubMed ID: 16929787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of monoclonal immunoglobulin heavy chain gene rearrangement (FR3) in Thai malignant lymphoma by High Resolution Melting curve analysis.
    Kummalue T; Chuphrom A; Sukpanichanant S; Pongpruttipan T; Sukpanichanant S
    Diagn Pathol; 2010 May; 5():31. PubMed ID: 20482846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
    Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
    Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma.
    Abdel-Reheim FA; Edwards E; Arber DA
    Arch Pathol Lab Med; 1996 Apr; 120(4):357-63. PubMed ID: 8619747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
    Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
    Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.
    Sata H; Shibayama H; Maeda I; Habuchi Y; Nakatani E; Fukushima K; Fujita J; Ezoe S; Tadokoro S; Maeda T; Mizuki M; Kosugi S; Nakagawa M; Ueda S; Iida M; Tokumine Y; Azenishi Y; Mitsui H; Oritani K; Kanakura Y
    Exp Hematol; 2015 May; 43(5):374-381.e2. PubMed ID: 25591497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides.
    Takamatsu H; Ogawa Y; Kobayashi N; Obata K; Narisawa T; Nakayama K; Munemoto S; Aoki G; Ohata K; Kumano Y; Ozaki J; Murata R; Kondo Y; Terasaki Y; Kurokawa T; Miyamoto T; Shimizu N; Fukushima T; Yoshida A; Ueda T; Yoshida T; Nakao S
    Exp Hematol; 2013 Oct; 41(10):894-902. PubMed ID: 23727584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.